Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 40, 2010 - Issue 6
104
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Synthesis of 2[(1R,2R)-2-(2,4-Difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-yl)propyl]-4-[4-tetrafluoropropoxy)phenyl]-3-(2H,4H)-1,2,4-triazol-3-thione—A Novel and Potent Azole Antifungal Agent

, &
Pages 833-838 | Received 21 Jan 2009, Published online: 22 Feb 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jyothis Devasia, Aatika Nizam & Vasantha V. L.. (2022) Azole-Based Antibacterial Agents: A Review on Multistep Synthesis Strategies and Biology. Polycyclic Aromatic Compounds 42:8, pages 5474-5495.
Read now

Articles from other publishers (2)

Elham Ghobadi, Shahnaz Saednia & Saeed Emami. (2022) Synthetic approaches and structural diversity of triazolylbutanols derived from voriconazole in the antifungal drug development. European Journal of Medicinal Chemistry 231, pages 114161.
Crossref
Jitendra A. Sattigeri, Sachin Sethi & Mohammad Salman. (2010) ChemInform Abstract: Synthesis of 2[(1R,2R)‐2‐(2,4‐difluorophenyl)‐2‐hydroxy‐1‐methyl‐3‐ (1H‐1,2,4‐triazol‐yl)propyl]‐4‐ [4‐tetrafluoropropoxyphenyl]‐3‐(2H,4H)‐1,2,4‐triazol‐3‐thione — A Novel and Potent Azole Antifungal Agent.. ChemInform 41:32.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.